Rigel Pharmaceuticals (RIGL) Capital Expenditures (QoQ) (2010 - 2022)
Rigel Pharmaceuticals (RIGL) Capital Expenditures (QoQ) (2010 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Rigel Pharmaceuticals |
603.18 Mn |
456.49 Mn |
54.21 Mn |
| Date | Value |
|---|
| Dec 31, 2022 |
-61.38% |
| Sep 30, 2022 |
625.00% |
| Jun 30, 2022 |
-116.07% |
| Mar 31, 2022 |
1,166.67% |
| Dec 31, 2021 |
-112.35% |
| Sep 30, 2021 |
-58.23% |
| Jun 30, 2021 |
473.24% |
| Mar 31, 2021 |
-85.91% |
| Dec 31, 2020 |
158.46% |
| Sep 30, 2020 |
543.18% |
| Jun 30, 2020 |
-107.25% |
| Mar 31, 2020 |
-0.65% |
| Dec 31, 2019 |
73.58% |
| Sep 30, 2019 |
206.09% |
| Jun 30, 2019 |
-69.50% |
| Mar 31, 2019 |
446.38% |
| Dec 31, 2018 |
-55.77% |
| Sep 30, 2018 |
-77.19% |
| Jun 30, 2018 |
247.21% |
| Mar 31, 2018 |
271.70% |
